Alphatec Holdings, a medical device company marketing treatment products for spinal disorders, reported $45.4 million in consolidated revenues for the second quarter of 2010, a 54.5 percent increase over the second quarter of 2009, according to a company news release.
Highlights in Alphatec's second quarter success include approval of the company's OsseoScrew in Europe and record surgical procedure volume in the United States. This quarter, Alphatec also held the company's first combined international distributer sales meeting as well as added two members to the senior management team.
Gross profit for the second quarter of 2010 was $28.8 million, an increase of 44.5 percent from the second quarter of 2009. Total operating expenses for the second quarter were $31.9 million, an increase from previous quarters due to the company's acquisition in European operations. The acquisition also increased sales and marketing expenses for the second quarter were $17.1 million from the 2009 second quarter expenses reported as $12.3 million.
Read the release on the 2Q FY 2010 report for Alphatec Holdings.
Read other coverage on Alphatec Holdings:
- Alphatec Holdings Announces 19.4% Growth in U.S. Spine Market for Q1
- Alphatec Acquires Scient'x Groupe
Highlights in Alphatec's second quarter success include approval of the company's OsseoScrew in Europe and record surgical procedure volume in the United States. This quarter, Alphatec also held the company's first combined international distributer sales meeting as well as added two members to the senior management team.
Gross profit for the second quarter of 2010 was $28.8 million, an increase of 44.5 percent from the second quarter of 2009. Total operating expenses for the second quarter were $31.9 million, an increase from previous quarters due to the company's acquisition in European operations. The acquisition also increased sales and marketing expenses for the second quarter were $17.1 million from the 2009 second quarter expenses reported as $12.3 million.
Read the release on the 2Q FY 2010 report for Alphatec Holdings.
Read other coverage on Alphatec Holdings:
- Alphatec Holdings Announces 19.4% Growth in U.S. Spine Market for Q1
- Alphatec Acquires Scient'x Groupe